Literature DB >> 30244358

An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.

Keiko Hashimoto1, Takashi Sano2, Yukari Honma1, Maoko Ida1, Hiroshi Tominaga1, Aya Sawada1, Tetsuya Abe1, Haruka Takahashi1, Yoshitaka Shimada1, Takanori Masaki1, Mariko Kamata1, Shokichi Naito1, Togo Aoyama1, Yasuo Takeuchi1, Masashi Akiya3, Madoka Inukai3, Norihiro Nakata3.   

Abstract

TAFRO syndrome (thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly) is an atypical manifestation of multicentric Castleman's disease. Although overproduction of interleukin-6, vascular endothelial growth factor, and other cytokines may partially explain the pathophysiology of this rare syndrome, the precise mechanisms underlying the renal dysfunction associated with the condition remain unclear. Here, we describe a case of a 69-year-old male with TAFRO syndrome. He was treated with immunosuppressive agents and his renal function improved. Tapering of immunosuppressive agents resulted in a deterioration of renal function and an elevation of C-reactive protein. After 20 months of treatment, the patient died from tuberculous peritonitis and gastrointestinal bleeding. An autopsy revealed miliary tuberculosis, mediastinal lymphadenopathy, and gastric ulcers. Renal histopathology showed a membranoproliferative glomerulonephritis-like appearance. Almost all glomeruli showed lobular formations with mesangial proliferation and duplication of glomerular capillary walls on light microscopy. Immunofluorescence showed deposition of C1q and IgM along the glomerular capillary walls. Electron microscopy showed mesangial expansion and widening of the subendothelial space with a large number of electron-dense deposits. The glomerular lesions might be characteristic of TAFRO syndrome, and were regarded as the main cause of the patient's renal dysfunction.

Entities:  

Keywords:  Hypercytokinemia; Membranoproliferative glomerulonephritis-like lesions; Renal dysfunction; TAFRO syndrome

Mesh:

Year:  2018        PMID: 30244358      PMCID: PMC6361076          DOI: 10.1007/s13730-018-0363-9

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  4 in total

1.  Liver cirrhosis in a child associated with Castleman's disease: A case report.

Authors:  Soya Kobayashi; Ayano Inui; Tomoyuki Tsunoda; Syuichiro Umetsu; Tsuyoshi Sogo; Masaaki Mori; Masato Shinkai; Tomoo Fujisawa
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

2.  Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.

Authors:  Sylvain Raoul Simeni Njonnou; Justine Deuson; Claire Royer-Chardon; Frédéric Alain Vandergheynst; Virginie De Wilde
Journal:  BMJ Case Rep       Date:  2020-06-30

Review 3.  Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.

Authors:  Amélie Leurs; Viviane Gnemmi; Arnaud Lionet; Loïc Renaud; Jean-Baptiste Gibier; Marie-Christine Copin; Eric Hachulla; Pierre-Yves Hatron; David Launay; David Fajgenbaum; Louis Terriou
Journal:  Front Immunol       Date:  2019-06-28       Impact factor: 8.786

4.  An Autopsy Case of TAFRO Syndrome with Type II Respiratory Failure.

Authors:  Mikio Wada; Akihiro Nagata; Atsushi Kawashima; Keizo Kagawa
Journal:  Am J Case Rep       Date:  2020-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.